VSTM
Verastem, Inc.
stockNASDAQ
Market OpenOct 15, 2026 2:24:35 PM EDT
9.32USD+20.947%(+1.61)11,697,660
Pre-marketOct 15, 2026 9:27:30 AM EDT
8.18USD+6.096%(+0.47)
Loading…
Loading…
839.52M
Healthcare
Biotechnology
HQ
Needham, MA, USA
Previous Close
$7.71
Beta
0.99
52-Week High
$10.82 2025-11-26
52-Week Low
$3.43 2026-06-25
SMA 50
$7.49
SMA 200
$6.04
Avg. Vol 10D
6.13M
Avg. Vol 30D
3.70M
Avg. Vol 90D
2.83M
Relative Vol
3.01
90.56M
70.38M
77.71%
14,964,825
21.26%
6.97
59%/41%
53.47%
39.47%
0.4100%
1,700,000
5,469
14,427
45,282
Nov 3, 2026 (19d)
Jun 1, 2023 · 1-for-12 (reverse)
Oct 15, 2026
Verastem’s KRAS inhibitor posts wins in mPDAC, mCRC and NSCLC · 
Clinical Trials Arena
Oct 14, 2026
Verastem cancer drug shows early promise in small study · 
BioPharma Dive
VSTM Profile
verastem, inc. (nasdaq: vstm) is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. cancer stem cells are an underlying cause of tumor recurrence and metastasis. verastem is translating breakthrough discoveries in cancer stem cell research into new medicines for the treatment of major cancers such as breast cancer. for more information, please visit www.versatem.com
VSTM Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 8.11 | 2026-10-08 | +14.30% | -1.500 |
| 1M | 7.34 | 2026-09-15 | +26.29% | 1.403 |
| 3M | 5.73 | 2026-07-15 | +61.78% | 0.425 |
| 6M | 6.33 | 2026-04-15 | +46.45% | 0.530 |
| 1Y | 9.40 | 2025-10-15 | -1.38% | 0.992 |
| 2Y | 3.13 | 2024-10-15 | +196.17% | — |
| 5Y | 33.12 | 2021-10-15 | -72.01% | 1.536 |
VSTM Stock Summary
Verastem, Inc. (NASDAQ:VSTM) stock price today is $9.27, and today's volume is 11,152,746. VSTM is up 20.233% today. The 30 day average volume is 3.70M. VSTM market cap is $839.52M with 90.56M shares outstanding.